464 related articles for article (PubMed ID: 31220559)
1. Quercetin inhibited mesangial cell proliferation of early diabetic nephropathy through the Hippo pathway.
Lei D; Chengcheng L; Xuan Q; Yibing C; Lei W; Hao Y; Xizhi L; Yuan L; Xiaoxing Y; Qian L
Pharmacol Res; 2019 Aug; 146():104320. PubMed ID: 31220559
[TBL] [Abstract][Full Text] [Related]
2. YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy.
Qian X; He L; Hao M; Li Y; Li X; Liu Y; Jiang H; Xu L; Li C; Wu W; Du L; Yin X; Lu Q
Acta Diabetol; 2021 Jan; 58(1):47-62. PubMed ID: 32816106
[TBL] [Abstract][Full Text] [Related]
3. Hyperactivation of YAP/TAZ Drives Alterations in Mesangial Cells through Stabilization of N-Myc in Diabetic Nephropathy.
Choi S; Hong SP; Bae JH; Suh SH; Bae H; Kang KP; Lee HJ; Koh GY
J Am Soc Nephrol; 2023 May; 34(5):809-828. PubMed ID: 36724799
[TBL] [Abstract][Full Text] [Related]
4. Sestrin2 attenuates renal damage by regulating Hippo pathway in diabetic nephropathy.
Bian Y; Shi C; Song S; Mu L; Wu M; Qiu D; Dong J; Zhang W; Yuan C; Wang D; Zhou Z; Dong X; Shi Y
Cell Tissue Res; 2022 Oct; 390(1):93-112. PubMed ID: 35821438
[TBL] [Abstract][Full Text] [Related]
5. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
6. Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.
Yang T; Heng C; Zhou Y; Hu Y; Chen S; Wang H; Yang H; Jiang Z; Qian S; Wang Y; Wang J; Zhu X; Du L; Yin X; Lu Q
Metabolism; 2020 Jul; 108():154258. PubMed ID: 32376130
[TBL] [Abstract][Full Text] [Related]
7. Epiberberine ameliorated diabetic nephropathy by inactivating the angiotensinogen (Agt) to repress TGFβ/Smad2 pathway.
Xiao Y; Deng J; Li C; Gong X; Gui Z; Huang J; Zhang Y; Liu Y; Ye X; Li X
Phytomedicine; 2021 Mar; 83():153488. PubMed ID: 33571918
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hypertrophy in early diabetic nephropathy mice by targeting GAS1.
Zhang L; He S; Guo S; Xie W; Xin R; Yu H; Yang F; Qiu J; Zhang D; Zhou S; Zhang K
J Diabetes Complications; 2014; 28(3):259-64. PubMed ID: 24560136
[TBL] [Abstract][Full Text] [Related]
9. MUC1 Promotes Mesangial Cell Proliferation and Kidney Fibrosis in Diabetic Nephropathy Through Activating STAT and β-Catenin Signal Pathway.
Tao Y; Han J; Liu W; An L; Hu W; Wang N; Yu Y
DNA Cell Biol; 2021 Oct; 40(10):1308-1316. PubMed ID: 34520253
[TBL] [Abstract][Full Text] [Related]
10. Proximal tubule-derived exosomes contribute to mesangial cell injury in diabetic nephropathy via miR-92a-1-5p transfer.
Tsai YC; Kuo MC; Hung WW; Wu PH; Chang WA; Wu LY; Lee SC; Hsu YL
Cell Commun Signal; 2023 Jan; 21(1):10. PubMed ID: 36639674
[TBL] [Abstract][Full Text] [Related]
11. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
[TBL] [Abstract][Full Text] [Related]
12. The mTOR promotes oxidative stress-induced apoptosis of mesangial cells in diabetic nephropathy.
Lu Q; Zhou Y; Hao M; Li C; Wang J; Shu F; Du L; Zhu X; Zhang Q; Yin X
Mol Cell Endocrinol; 2018 Sep; 473():31-43. PubMed ID: 29277549
[TBL] [Abstract][Full Text] [Related]
13. Carnosic acid improves diabetic nephropathy by activating Nrf2/ARE and inhibition of NF-κB pathway.
Xie Z; Zhong L; Wu Y; Wan X; Yang H; Xu X; Li P
Phytomedicine; 2018 Aug; 47():161-173. PubMed ID: 30166101
[TBL] [Abstract][Full Text] [Related]
14. Transcription Factor Egr1 is Involved in High Glucose-Induced Proliferation and Fibrosis in Rat Glomerular Mesangial Cells.
Wang D; Guan MP; Zheng ZJ; Li WQ; Lyv FP; Pang RY; Xue YM
Cell Physiol Biochem; 2015; 36(6):2093-107. PubMed ID: 26279418
[TBL] [Abstract][Full Text] [Related]
15. The topological key lncRNA H2k2 from the ceRNA network promotes mesangial cell proliferation in diabetic nephropathy
Chen W; Peng R; Sun Y; Liu H; Zhang L; Peng H; Zhang Z
FASEB J; 2019 Oct; 33(10):11492-11506. PubMed ID: 31336052
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of ANGPTL-4 inhibits inflammatory response and extracellular matrix accumulation in glomerular mesangial cells cultured under high glucose condition.
Qin L; Zhang R; Yang S; Chen F; Shi J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3368-3373. PubMed ID: 31387395
[TBL] [Abstract][Full Text] [Related]
17. Corosolic acid inhibits the proliferation of glomerular mesangial cells and protects against diabetic renal damage.
Li XQ; Tian W; Liu XX; Zhang K; Huo JC; Liu WJ; Li P; Xiao X; Zhao MG; Cao W
Sci Rep; 2016 May; 6():26854. PubMed ID: 27229751
[TBL] [Abstract][Full Text] [Related]
18. Klotho attenuates diabetic nephropathy in db/db mice and ameliorates high glucose-induced injury of human renal glomerular endothelial cells.
Wang Q; Ren D; Li Y; Xu G
Cell Cycle; 2019; 18(6-7):696-707. PubMed ID: 30784349
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
[TBL] [Abstract][Full Text] [Related]
20. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses.
Chen J; Hou XF; Wang G; Zhong QX; Liu Y; Qiu HH; Yang N; Gu JF; Wang CF; Zhang L; Song J; Huang LQ; Jia XB; Zhang MH; Feng L
J Ethnopharmacol; 2016 Dec; 193():433-444. PubMed ID: 27664441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
